ZimVie Archives - Medical Design Sourcing

ZimVie expands development deal with Brainlab to include co-marketing

ZimVie (Nasdaq: ZIMV) + announced today that it expanded its cooperation agreement with Brainlab.

Brainlab offers a diversified spine imaging, planning and navigation portfolio. It also provides robotic imaging, surgical assistance and mixed reality to support spinal surgeries.

Westminster, Colorado-based ZimVie and Brainlab undertook a joint project to achieve compatibility between technologies. It aims to combine ZimVie’s Vital and Virage fixation systems with Brainlab’s spine and trauma navigation technologies. These help surgeons plan and execute spinal procedures, accurately place pedicle screws and minimize radiation exposure.

Additionally, ZimVie intends to co-market the Brainlab spine and trauma navigation technologies alongside its existing spine implant solutions.

“We are excited to partner with Brainlab to bring into the operating room differentiated technology aiming at enhancing w…

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]

Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product launches between this year and the end of 2025, the …

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker] Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker (NYSE: SYK) + and Zimmer Biomet (NYSE: ZBH) + both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product …

FDA grants new approval for ZimVie Mobi-C implant, plans U.S. launch in the fall

The Mobi-C cervical disc [Image courtesy of ZimVie]ZimVie (Nasdaq: ZIMV) + announced today that the FDA approved a smaller height of its Mobi-C cervical disc.

The updated approval covers Mobi-C in seven footprints that address the anatomical needs of patients in the U.S. Mobi-C has been used for cervical disc replacement to treat patients in France since 2004. In 2013, it became the first cervical disc approved for one and two contiguous levels by the FDA.

“The approval of the 4.5mm Mobi-C is a win for our surgeons and their patients, as well as a validation of thoughtful strategy by our global regulatory affairs team who utilized real-world clinical evidence gained from EU studies to show long-term safety and efficacy and secure the FDA approval for the smaller disc,” said Rebecca Whitney, global president of ZimVie Spine. “We are pleased to provide surgeons the largest range of footprint and height options in the market…

July 2023 edition: Life-saving LVADs, supplier innovations and AI breakthroughs

LVADs save lives: So why aren’t more available?

What’s new in 3D printing: medical devices, research, innovation, automation and partnerships

AI breakthroughs in medtech: 7 ways to enhance healthcare

Life-saving LVADs, supplier innovations and AI breakthroughs

Kyree Miller recalls the day his heart stopped beating.

“I remember the entire room going white,” he said. “And I actually turned over on my side and I said, ‘Tell my mom I love her.’”

A couple of weeks later, the heart failure patient — who was only in his 20s at the time — received his first left ventricular assist device (LVAD) implant while he waited for a heart transplant. One year passed, then two, then three. Finally, after surviving on LVAD technology for seven years, his new heart came.

“When you get your transplant, there’s a whole new energy that you get. … But I can honestly say there was a whole new energy that I got when I had my LVAD,” Miller said.

…

They said it at DeviceTalks Boston 2023

Medical device industry leaders from Boston Scientific, Abbott, ZimVie, Medtronic, Stryker and more met at DeviceTalks Boston to share lessons learned and their perspectives on industry trends, device design and medtech innovation.

BD Chair, CEO and President Tom Polen (right) at DeviceTalks Boston with DeviceTalks Editorial Director Tom Salemi [Photo by Jeff Pinette for Medical Design & Outsourcing]

Bidding farewell to DeviceTalks Boston 2023, we look back at an exceptional two-day medical device conference teeming with insights from over 100 top industry leaders.

These experts unfolded many complexities of the medtech industry in more than 35 sessions, walking attendees from the medical device product development continuum through the latest medical innovations and strategies to tackle regulatory challenges, prototyping, manufacturing, product launches and more.

Between the high-profile keynote int…

DeviceTalks Boston: The ZimVie Tether helps kids with scoliosis — if they can get it in time

The ZimVie Tether system is FDA approved for adolescent idiopathic scoliosis under a humanitarian device exemption. [Image courtesy of ZimVie]The ZimVie (Nasdaq:ZIMV) Tether is a groundbreaking system for treating adolescent idiopathic scoliosis, developed with the help of surgeons who saw an opportunity to improve the lives of their pediatric patients.

But for every patient the clock is ticking, as children are only eligible if they have enough growth ahead of them for the technology to make a difference. And all too often, insurance companies can delay the treatment so long that patients are no longer eligible if and when insurers approve the procedure.

ZimVie SVP and Global Spine President Rebecca Whitney spoke about the systems development and commercialization with ZimVie Spine Global R&D Director Ryan Watson today at DeviceTalks Boston.

“We’ve worked for years to make sure that we have the right options available for these kids because it is a spe…

The ZimVie Tether helps kids with scoliosis — if they can get it in time

The ZimVie Tether system is FDA approved for adolescent idiopathic scoliosis under a humanitarian device exemption. [Image courtesy of ZimVie]

The ZimVie Tether is a groundbreaking system for treating adolescent idiopathic scoliosis, developed with the help of surgeons who saw an opportunity to improve the lives of their pediatric patients.

But for every patient the clock is ticking, as children are only eligible if they have enough growth ahead of them for the technology to make a difference. And all too often, insurance companies can delay the treatment so long that patients are no longer eligible if and when insurers approve the procedure.

ZimVie SVP and Global Spine President Rebecca Whitney spoke about the system’s development and commercialization with ZimVie Spine Global R&D Director Ryan Watson today at DeviceTalks Boston.

Re…

ZimVie discloses executive pay and severance for first C-suite exit

ZimVie executive pay is public for the first time a year after the spine and dental device developer spun off from Zimmer Biomet.

Westminster, Colorado–based ZimVie (Nasdaq:ZIMV) disclosed pay for its top executives in late March ahead of the May 12 inaugural annual meeting of shareholders. Investors will weigh in on the executive pay packages for the first time in an advisory “say-on-pay” vote.

One of those executives is no longer with ZimVie. In annual proxy filings with the Securities and Exchange Committee, the company said former SVP and Chief Human Resources Officer David Harmon “separated from the company” on Jan. 13, 2023.

Harmon joined ZimVie in September 2021 and was announced as part of the leadership team before the spinoff launched in March 2022. He was previously the chief people officer at Gannett; he now lists himself as self-employed on his LinkedIn profile.

The proxy filing doesn’t say why Ha…

ZimVie is laying off 5% of workforce, stock still soars on Q1 results

ZimVie (Nasdaq:ZIMV) + shares ticked up today on first-quarter financial results despite the announcement of a workforce reduction.

Shares of ZimVie rose 22.8% at $9.47 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.5%.

The Westminster, Colorado-based dental and spine company said it recently initiated additional restructuring activities. It aims to better position the organization for future success based on the current business environment.

Through these initiatives, ZimVie hopes to reduce its global cost structure and streamline its organizational infrastructure. As a result, the company expects an approximate 5% global workforce reduction. (The company’s most recent annual report listed 2,700 employees, so the layoff could be equivalent to roughly 135 workers.)

The job cuts come in additi…

ZimVie opens state-of-the-art dental training facility in Florida

[Image courtesy of ZimVie]ZimVie (Nasdaq:ZIMV) announced today that it opened a new, state-of-the-art educational facility for dental practitioners.

Westminster, Colorado-based ZimVie built its facility in Palm Beach Gardens, Florida. The “ZimVie Institute South” features more than 11,000 square feet of dedicated education and training space. It offers life-like simulated patient models, a cadaver lab and a fully integrated digital workflow.

ZimVie, the Zimmer Biomet dental and spine spinoff, said the facility also has 3D printing capabilities, RealGuide software and a mill.

According to a news release, the facility expands its institute model to enable the company to host cadaver and simulation courses. These courses teach advanced surgical and restorative techniques for full mouth reconstructions. The institute also hosts comprehensive training events covering everything from practice management to digital workflow training.

Located at …

ZimVie wins positive coverage decisions for pediatric scoliosis device

The Tether VBT system. [Image from ZimVie]ZimVie (Nasdaq:ZIMV) announced today that the Highmark insurance organization issued positive medical policy decisions applicable to vertebral body tethering (VBT).

Highmark is an independent licensee of the Blue Cross Blue Shield Association. It primarily covers Pennsylvania, New York, Delaware, and West Virginia and BCBS North Dakota.

The new policy decisions went into effect Jan. 30, 2023, for Highmark and March 6, 2023, for BCBS North Dakota. It outlines the criteria for medical necessity and expands potential treatment eligibility to patients indicated for VBT, ZimVie said. According to a news release, it applies to more than 4 million members covered under Highmark and 280,000 under BCBS North Dakota.

In particular, the policy decisions benefit the ZimVie Tether device. ZimVie designed Tether as a first-of-its-kind, non-fusion scoliosis treatment. The company said it marks the only FDA-approved device for VBT.…